Clarivate Plc Stock Price, News & Analysis

Clarivate Plc (NYSE: CLVT) announced it will release its second quarter 2022 financial results on August 9, 2022, prior to market opening. The earnings report and financial details will be available on the investor website. A conference call and webcast to discuss the results will occur on the same day at 9:00 AM Eastern Time. Interested parties can join the call via a dedicated phone line or access the live webcast through the company’s investor relations site. A replay will be available for a limited time following the call.

Clarivate Plc (NYSE: CLVT) has been selected for the second consecutive time to provide citation data for the Australian Research Council's Excellence in Research for Australia (ERA) 2023. This initiative aims to evaluate research excellence across Australian universities. Utilizing The Web of Science™, Clarivate will support the ARC in assessing research quality through citation indicators and peer reviews. Clarivate has been involved with ERA since its inception in 2010, continually implementing improvements to enhance research evaluations.

Clarivate Plc (NYSE: CLVT) has released its 2022 Journal Citation Reports (JCR), highlighting ongoing increases in citation impact for journals publishing COVID-19 research. Notably, The Lancet now holds the top Journal Impact Factor of 202.731, surpassing the New England Journal of Medicine, while Nature becomes the first journal to exceed one million citations in a year. The JCR assesses over 21,000 journals with rigorous criteria, emphasizing the profound influence of COVID-19 on academic publishing.

Clarivate Plc (NYSE: CLVT) announced that Jerre Stead and Jonathan Collins will present at investor conferences in June 2022. Key dates include the Stifel 2022 Cross Sector Insight Conference on June 7, 2022, at 9:10 AM ET, and the William Blair’s 42nd Annual Growth Stock Conference on June 9, 2022, at 2:20 PM ET. Live webcasts will be available for both events, with replays accessible afterwards. Clarivate aims to provide solutions that accelerate innovation across various sectors, including Life Sciences and Technology.

Clarivate Plc (NYSE:CLVT; CLVT PR A) announced a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares. This dividend will be paid in cash on June 1, 2022, to shareholders of record as of May 13, 2022. This decision reflects the company's commitment to returning value to its shareholders while maintaining its focus on providing trusted information and insights that accelerate innovation.

Clarivate Plc (CLVT) reported strong financial results for Q1 2022, with revenues soaring to $662.2 million, a 54.6% increase year-over-year. Organic revenues rose 4.4%, while net income improved by $106.8 million to $50.8 million. Adjusted EBITDA also saw significant growth, up 59.2% to $262.3 million. Subscription revenues increased 69%, driven by the ProQuest acquisition. However, net cash provided by operating activities decreased by 61.3% to $67.4 million, primarily due to payroll payments. The company reaffirmed its positive outlook for 2022.

Clarivate Plc (NYSE:CLVT) released a new report detailing the evolving trademark landscape influenced by technological advancements like NFTs, metaverse, and cryptocurrency. Key findings reveal a nearly 9,000% increase in NFT-related trademark applications since 2018, with Class 9 filings rising to the second position globally in 2021. Despite overall growth in trademark filings for the 10th consecutive year, filings in Class 10 decreased by 22%. The report emphasizes the significance of intellectual property management in a competitive digital market.